Cambridge biotech Relay races past goals in $400M IPO
July 16, 2020 at 10:20 AM EDT
Cancer startup Relay Therapeutics raised $400 million in its IPO Thursday, doubling the plans it laid out last month.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|